Responses were determined separately for sporadic and NF1-associated MPNST, as response to chemotherapy and outcome have been reported to be worse for NF1-associated compared to sporadic MPNST as noted by Ferrari et al. [3, 14]. This evidence concerns the gene NF1 and malignant peripheral nerve sheath tumor.